Atreca, Inc. Skyrocketed
Atreca, Inc. (BCEL:NASDAQ) rocketted at $0.23, a gain of 118%. On Thu, Jan 11, 2024, BCEL:NASDAQ hit a New 2-Week High of $0.23. The stock got featured on our News Catalysts scanner on Tue, Dec 26, 2023 at 12:50 PM in the 'ACQUISITION' category. From Thu, Dec 28, 2023, the stock recorded 11.11% Up Days and 10.00% Green Days
The stock spiked on Thu, Oct 19, 2023 at $0.42 with a volume of 16M+.
About Atreca, Inc. (BCEL:NASDAQ)
Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.
Top 10 Gainers:
- Unico American Corporation (UNAM:NASDAQ), 246.88%
- Atreca, Inc. (BCEL:NASDAQ), 118.02%
- E-Home Household Service Holdings Limited (EJH:NASDAQ), 69.75%
- SEALSQ Corp. (LAES:NASDAQ), 62.56%
- Nubia Brand International Corp. (NUBI:NASDAQ), 48.66%
- First Financial Northwest, Inc. (FFNW:NASDAQ), 48.03%
- Swvl Holdings Corp (SWVL:NASDAQ), 37.67%
- Sagimet Biosciences Inc. (SGMT:NASDAQ), 36.14%
- Moolec Science SA (MLEC:NASDAQ), 31.77%
- WISeKey International Holding AG (WKEY:NASDAQ), 30.8%